Previous Article | Next Article 
Journal of Clinical Microbiology, September 2007, p. 3146-3147, Vol. 45, No. 9
0095-1137/07/$08.00+0 doi:10.1128/JCM.00132-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Emergence of an Epidemic Clone of Community-Associated Methicillin-Resistant Panton-Valentine Leucocidin-Negative Staphylococcus aureus in Cystic Fibrosis Patient Populations

LETTER
The article by Moroney et al. (
3) documents the increased prevalence
of community-associated methicillin-resistant
Staphylococcus aureus (CA-MRSA) strains in different patient populations. Most
of the CA-MRSA strains characterized by carriage of staphylococcal
cassette chromosome
mec (SCC
mec) type IV were also positive
for the Panton-Valentine leucocidin (PVL) gene 1 (
2). However,
this gene association is not necessarily indicative of CA-MRSA
strains. We analyzed the prevalence and molecular epidemiology
of MRSA from the airways of cystic fibrosis (CF) patients in
an Italian multicenter study. One hundred eighty-one (7.6%)
out of 2,362 CF patients attending 9 Italian CF centers were
infected with MRSA. A high prevalence (36%) of SCC
mec IV (suggestive
of CA-MRSA strains) was found (
5). Pulsed-field gel electrophoresis
analysis showed a single MRSA clone colonizing 31 patients in
6 centers. Twenty-four out of 31 strains (77.4%) revealed SCC
mec type IV, mostly associated with CA-MRSA. All the SCC
mec type
IV MRSA isolates belonging to the epidemic clone were negative
for the PVL genes, as reported by other authors (
4).
The high prevalence of MRSA strains, suggestive of CA-MRSA in a patient population considered at risk for hospital-associated (HA)-MRSA acquisition, is worrisome evidence supporting current opinions that CA-MRSA strains are replacing HA-MRSA strains in health care settings (1, 6).
The interesting question of whether the CA-MRSA clone infected the CF patients in the community or whether the patients acquired the clone in the hospital which they attended regularly is unclear and needs to be further studied.

ACKNOWLEDGMENTS
We thank the Fondazione per la Ricerca sulla Fibrosi Cistica-ONLUS
for its grant (FFC no. 12 2006).

REFERENCES
1 - Gonzalez, B. E., et al. 2006. Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection. Infect. Control Hosp. Epidemiol. 27:1051-1056.[CrossRef][Medline]
2 - Holmes, A., et al. 2005. Staphylococcus aureus Isolates Carrying Panton-Valentine Leucocidin Genes in England and Wales: Frequency, Characterization, and Association with Clinical Disease. J. Clin. Microbiol. 43:2384-2390.[Abstract/Free Full Text]
3 - Moroney, S. M., et al. 2007. Staphylococcal cassette chromosome mec (SCCmec) and Panton-Valentine leukocidin characterization of methicillin-resistant Staphylococcus aureus clones. J. Clin. Microbiol. 45:1019-1021.[Abstract/Free Full Text]
4 - O'Brien, F. G., et al. 2004. Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J. Clin. Microbiol. 42:3185-3190.[Abstract/Free Full Text]
5 - Oliveira, D. C., and H. de Lencastre. 2002. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46:2155-2166.[Abstract/Free Full Text]
6 - Seybold, U., et al. 2006. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin. Infect. Dis. 42:647-656.[CrossRef][Medline]
| | | | | |
Silvia Campana*
Cystic Fibrosis Center Department of Paediatrics University of Florence Via Luca Giordano 13 Florence 50132, Italy
Priscilla Cocchi
Cystic Fibrosis Center Department of Paediatrics University of Florence Florence, Italy
Gerd Döring
Institute of Medical Microbiology and Hygiene University of Tübingen Tübingen, Germany
Giovanni Taccetti
Cystic Fibrosis Center Department of Paediatrics University of Florence Florence, Italy
|
| | | | | |
* Phone and fax: 0039 0555662509 E-mail: s.campana{at}meyer.it |
Author's Reply

LETTER
I read with interest the letter from Silvia Campana et al. describing
an MRSA clone positive for SCC
mec type IV yet negative for PVL
present in their CF patient population. Numerous studies have
shown evidence that CA-MRSA is associated with the genes encoding
PVL (
1,
4,
5). In addition, there is a concomitant low rate
of PVL carriage in HA-MRSA isolates (
3,
5). We observed two
predominant SCC
mec IV CA-MRSA clones in our study, almost all
of which were PVL positive. However, we are also aware of several
reports of CA-MRSA SCC
mec IV strains which do not carry the
PVL toxin. I believe these studies, along with the author's
work, demonstrate that the molecular characteristics of CA-MRSA
isolates are indeed heterogeneous in nature and may vary among
different geographic locations. It is of interest whether the
CF patients studied presented with active infection or were
merely colonized with the CA-MRSA strain, since PVL has been
shown to be present less often in CA-MRSA isolates from asymptomatic
colonized individuals (
2). Nevertheless, the data represent
the migration of CA-MRSA into the health care setting and the
presence of CA-MRSA infection in patients with risk factors
for HA-MRSA. I agree that the high representation of CA-MRSA,
irrespective of PVL presence, in a hospital setting is troublesome
and may be rapidly blurring the line of distinction between
CA-MRSA and HA-MRSA infections.

REFERENCES
1 - Boyle-Vavra, S., and R. Daum. 2007. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab. Investig. 87:3-9.[CrossRef][Medline]
2 - Boyle-Vavra, S., B. Ereshefsky, C. C. Wang, and R. S. Daum. 2005. Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV. J. Clin. Microbiol. 43:4719-4730.[Abstract/Free Full Text]
3 - Deurenberg, R. H., C. Vink, S. Kalenic, A. W. Friedrick, C. A. Bruggeman,and E. E. Stobberingh. 2007. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 13:222-235.[CrossRef][Medline]
4 - Diederen, B. M., and J. A. Kluytmans. 2006. The emergence of infections with community-associated methicillin resistant Staphylococcus aureus. J. Infect. 52:157-168.[CrossRef][Medline]
5 - Vandenesch, F., T. Naimi, M. C. Enright, G. Lina, G. R. Nimmo, H. Heffernan, N. Liassine, M. Bes, T. Greenland, M. Reverdy, and J. Etienne. 2003. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 9:978-984.[Medline]
| | | | | |
Shannon M. Moroney
Esoteric Testing/Department of Pathology Tampa General Hospital P.O. Box 1289 Tampa, Florida 33601 Phone: (813) 844-4261, Fax: (813) 844-1312, E-mail: smoroney{at}tgh.org
|
| | | | | |
|
Journal of Clinical Microbiology, September 2007, p. 3146-3147, Vol. 45, No. 9
0095-1137/07/$08.00+0 doi:10.1128/JCM.00132-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Dasenbrook, E. C., Merlo, C. A., Diener-West, M., Lechtzin, N., Boyle, M. P.
(2008). Persistent Methicillin-resistant Staphylococcus aureus and Rate of FEV1 Decline in Cystic Fibrosis. Am. J. Respir. Crit. Care Med.
178: 814-821
[Abstract]
[Full Text]